Originally posted by Howie
View Post
Reports that the drug is a cannabis-based painkiller have been denied by the health ministry.
The drug is intended to help with mood, anxiety and motor problems linked to neurodegenerative diseases by having an effect on the endocannabinoid system, a set of brain receptors. Of 128 participants, 90 were given the drug, and the rest a placebo.
Contrary to several reports in the French news media, the drug was not a cannabis-based painkiller, Ms. Touraine said.
Bial identified the drug as an inhibitor of an enzyme known as FAAH, or fatty acid amide hydrolase. Other FAAH inhibitors have been tested safely in Phase 1 and Phase 2 clinical trials, said Andrea G. Hohmann, a professor of neuroscience at Indiana University who studies the endocannabinoid system and pain.
Bial identified the drug as an inhibitor of an enzyme known as FAAH, or fatty acid amide hydrolase. Other FAAH inhibitors have been tested safely in Phase 1 and Phase 2 clinical trials, said Andrea G. Hohmann, a professor of neuroscience at Indiana University who studies the endocannabinoid system and pain.
Only registered and activated users can see links., Click Here To Register...

Please Note that my posts may have been arbitrarily altered by a Moderator and may not reflect my original content.
Comment